BioCentury
ARTICLE | Finance

Bountiful, not bubbly

Why this week’s flurry of biotech IPOs on NASDAQ isn’t a sign of market froth

June 22, 2018 8:59 PM UTC

A compressed calendar, rather than investor overexuberance, accounts for one of the busiest weeks for IPO pricings in the sector’s history.

Seven NASDAQ IPOs were completed during the week ending June 22, raising a total of $718.9 million before potential overallotments...